Surfactant protein D is proatherogenic in mice
1 Medical Biotechnological Center, University of Southern Denmark, and 2 Department of Pathology, Odense University Hospital, Odense, Denmark; 3 Department of Biochemistry, Medical Research Council Immunochemistry Unit, University of Oxford, Oxford, United Kingdom; 4 Department of Pediatrics, Univer...
Saved in:
Published in | American journal of physiology. Heart and circulatory physiology Vol. 290; no. 6; pp. H2286 - H2294 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.06.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | 1 Medical Biotechnological Center, University of Southern Denmark, and 2 Department of Pathology, Odense University Hospital, Odense, Denmark; 3 Department of Biochemistry, Medical Research Council Immunochemistry Unit, University of Oxford, Oxford, United Kingdom; 4 Department of Pediatrics, University of California, Davis, California; 5 Copenhagen Blood Transfusion Centre, Copenhagen University Hospital, Copenhagen, Denmark; 6 Department of Pediatrics and Cardiovascular Research Institute, University of California, San Francisco, California; and 7 Department of Cardiology, Aarhus University Hospital (Skejby), Aarhus, Denmark
Submitted 19 October 2005
; accepted in final form 23 December 2005
Surfactant protein D (SP-D) is an important innate immune defense molecule that mediates clearance of pathogens and modulates the inflammatory response. Moreover, SP-D is involved in lipid homeostasis, and pulmonary accumulation of phospholipids has previously been observed in SP-D-deficient ( Spd/ ) mice. Atherogenesis involves both inflammation and lipid deposition, and we investigated the role of SP-D in the development of atherosclerosis. SP-D synthesis was localized to vascular endothelial cells. Atherosclerotic lesion areas were 5.6-fold smaller in the aortic roots in Spd/ mice compared with wild-type C57BL/6N mice on an atherogenic diet. HDL cholesterol (HDL-C) was significantly elevated in Spd/ mice. Treatment of Spd/ mice with a recombinant fragment of human SP-D resulted in decreases of HDL-C (21%) as well as total cholesterol (26%), and LDL cholesterol (28%). Plasma TNF- was reduced in Spd/ mice (45% difference). SP-D was proatherogenic in the mouse model used. The effect is likely to be due to the observed disturbances of plasma lipid metabolism and alteration of the inflammatory process, which underlie the reduced susceptibility to atherosclerosis in Spd/ mice.
atherosclerosis; experimental animals; high-density lipoprotein; tumor necrosis factor-
Address for reprint requests and other correspondence: U. Holmskov, Univ. of Southern Denmark, Medical Biotechnology Center, Winsloewparken 25,3, 5000 Odense C, Denmark (e-mail: uholmskov{at}health.sdu.dk ) |
---|---|
AbstractList | 1 Medical Biotechnological Center, University of Southern Denmark, and 2 Department of Pathology, Odense University Hospital, Odense, Denmark; 3 Department of Biochemistry, Medical Research Council Immunochemistry Unit, University of Oxford, Oxford, United Kingdom; 4 Department of Pediatrics, University of California, Davis, California; 5 Copenhagen Blood Transfusion Centre, Copenhagen University Hospital, Copenhagen, Denmark; 6 Department of Pediatrics and Cardiovascular Research Institute, University of California, San Francisco, California; and 7 Department of Cardiology, Aarhus University Hospital (Skejby), Aarhus, Denmark
Submitted 19 October 2005
; accepted in final form 23 December 2005
Surfactant protein D (SP-D) is an important innate immune defense molecule that mediates clearance of pathogens and modulates the inflammatory response. Moreover, SP-D is involved in lipid homeostasis, and pulmonary accumulation of phospholipids has previously been observed in SP-D-deficient ( Spd/ ) mice. Atherogenesis involves both inflammation and lipid deposition, and we investigated the role of SP-D in the development of atherosclerosis. SP-D synthesis was localized to vascular endothelial cells. Atherosclerotic lesion areas were 5.6-fold smaller in the aortic roots in Spd/ mice compared with wild-type C57BL/6N mice on an atherogenic diet. HDL cholesterol (HDL-C) was significantly elevated in Spd/ mice. Treatment of Spd/ mice with a recombinant fragment of human SP-D resulted in decreases of HDL-C (21%) as well as total cholesterol (26%), and LDL cholesterol (28%). Plasma TNF- was reduced in Spd/ mice (45% difference). SP-D was proatherogenic in the mouse model used. The effect is likely to be due to the observed disturbances of plasma lipid metabolism and alteration of the inflammatory process, which underlie the reduced susceptibility to atherosclerosis in Spd/ mice.
atherosclerosis; experimental animals; high-density lipoprotein; tumor necrosis factor-
Address for reprint requests and other correspondence: U. Holmskov, Univ. of Southern Denmark, Medical Biotechnology Center, Winsloewparken 25,3, 5000 Odense C, Denmark (e-mail: uholmskov{at}health.sdu.dk ) Surfactant protein D (SP-D) is an important innate immune defense molecule that mediates clearance of pathogens and modulates the inflammatory response. Moreover, SP-D is involved in lipid homeostasis, and pulmonary accumulation of phospholipids has previously been observed in SP-D-deficient ( Spd−/−) mice. Atherogenesis involves both inflammation and lipid deposition, and we investigated the role of SP-D in the development of atherosclerosis. SP-D synthesis was localized to vascular endothelial cells. Atherosclerotic lesion areas were 5.6-fold smaller in the aortic roots in Spd−/− mice compared with wild-type C57BL/6N mice on an atherogenic diet. HDL cholesterol (HDL-C) was significantly elevated in Spd−/− mice. Treatment of Spd−/− mice with a recombinant fragment of human SP-D resulted in decreases of HDL-C (21%) as well as total cholesterol (26%), and LDL cholesterol (28%). Plasma TNF-α was reduced in Spd−/− mice (45% difference). SP-D was proatherogenic in the mouse model used. The effect is likely to be due to the observed disturbances of plasma lipid metabolism and alteration of the inflammatory process, which underlie the reduced susceptibility to atherosclerosis in Spd−/− mice. Surfactant protein D (SP-D) is an important innate immune defense molecule that mediates clearance of pathogens and modulates the inflammatory response. Moreover, SP-D is involved in lipid homeostasis, and pulmonary accumulation of phospholipids has previously been observed in SP-D-deficient (Spd-/-) mice. Atherogenesis involves both inflammation and lipid deposition, and we investigated the role of SP-D in the development of atherosclerosis. SP-D synthesis was localized to vascular endothelial cells. Atherosclerotic lesion areas were 5.6-fold smaller in the aortic roots in Spd-/- mice compared with wild-type C57BL/6N mice on an atherogenic diet. HDL cholesterol (HDL-C) was significantly elevated in Spd-/- mice. Treatment of Spd-/- mice with a recombinant fragment of human SP-D resulted in decreases of HDL-C (21%) as well as total cholesterol (26%), and LDL cholesterol (28%). Plasma TNF-alpha was reduced in Spd-/- mice (45% difference). SP-D was proatherogenic in the mouse model used. The effect is likely to be due to the observed disturbances of plasma lipid metabolism and alteration of the inflammatory process, which underlie the reduced susceptibility to atherosclerosis in Spd-/- mice. |
Author | Nielsen, Claus H Falk, Erling Tornoe, Ida Madsen, Jens Kejling, Karin Poulain, Francis Holmskov, Uffe Sorensen, Grith L Nielsen, Ole Hawgood, Samuel Reid, Kenneth B. M Townsend, Paul |
Author_xml | – sequence: 1 fullname: Sorensen, Grith L – sequence: 2 fullname: Madsen, Jens – sequence: 3 fullname: Kejling, Karin – sequence: 4 fullname: Tornoe, Ida – sequence: 5 fullname: Nielsen, Ole – sequence: 6 fullname: Townsend, Paul – sequence: 7 fullname: Poulain, Francis – sequence: 8 fullname: Nielsen, Claus H – sequence: 9 fullname: Reid, Kenneth B. M – sequence: 10 fullname: Hawgood, Samuel – sequence: 11 fullname: Falk, Erling – sequence: 12 fullname: Holmskov, Uffe |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16387789$$D View this record in MEDLINE/PubMed |
BookMark | eNp1j9tOg0AQhjemxh70CUwMLwDdA7tAvDLVWpMmXlivN8syW7ahQBYa5e0FW603Xk1m5v9m8k3RqKxKQOiW4IAQTudqV-egXBtgQjAPKMb8Ak36DfUJZ8kITTATzBeE8TGaNs0O94lIsCs0JoLFURQnExS8HZxRulVl69WuasGW3qNnm6FRbQ6u2kJptdeP91bDNbo0qmjg5lRn6H35tFms_PXr88viYe3rUJDWNxRYEkKa6f5hbFJBKSgeMsJDynkCoKhiHEISxSrjkaHREMI65CkhikVshtjxrnZV0zgwsnZ2r1wnCZaDvfyxl9_2crDvqbsjVR_SPWRn5qTbB-bHQG63-Yd1IOu8a2xVVNvufJEmWAq5ojQWPXH_P7E8FMUGPttf9A8p68ywL3mmfzA |
CitedBy_id | crossref_primary_10_1016_j_atherosclerosis_2015_12_037 crossref_primary_10_1093_ntr_ntv243 crossref_primary_10_1111_j_1399_3038_2007_00695_x crossref_primary_10_2459_JCM_0b013e32835dbd24 crossref_primary_10_3389_fcimb_2020_00229 crossref_primary_10_1111_j_1365_3083_2006_01853_x crossref_primary_10_1152_ajpheart_91529_2007 crossref_primary_10_1016_j_jtcvs_2009_05_021 crossref_primary_10_1111_j_1365_3083_2007_01943_x crossref_primary_10_1517_14712598_8_4_409 crossref_primary_10_1186_s12917_021_02943_5 crossref_primary_10_1016_j_jim_2007_11_001 crossref_primary_10_3389_fmed_2018_00018 crossref_primary_10_1253_circj_CJ_17_1446 crossref_primary_10_3390_ijms25126418 crossref_primary_10_1165_rcmb_2006_0195OC crossref_primary_10_1007_s11427_019_9557_7 crossref_primary_10_1177_1753465808088903 crossref_primary_10_17116_terarkh2015871115_119 crossref_primary_10_1016_j_imbio_2012_08_272 crossref_primary_10_1111_j_1365_3083_2007_02039_x crossref_primary_10_1152_ajplung_00604_2020 crossref_primary_10_3389_fimmu_2021_652252 crossref_primary_10_1371_journal_pone_0035066 crossref_primary_10_1038_s41577_018_0004_8 crossref_primary_10_1093_cvr_cvx067 crossref_primary_10_1016_j_imbio_2007_01_003 crossref_primary_10_1164_rccm_200709_1356OC crossref_primary_10_1007_s00296_010_1538_7 crossref_primary_10_1093_cvr_cvx124 crossref_primary_10_1007_s00380_018_1153_1 crossref_primary_10_1111_apm_12785 crossref_primary_10_1111_j_1365_3083_2008_02187_x crossref_primary_10_3389_fimmu_2019_02264 crossref_primary_10_1586_ers_12_5 crossref_primary_10_1159_000369143 crossref_primary_10_1007_s11255_017_1728_2 crossref_primary_10_4049_jimmunol_1402289 crossref_primary_10_1186_1742_2094_11_123 crossref_primary_10_1016_j_clim_2007_03_001 crossref_primary_10_1016_j_imbio_2009_05_001 crossref_primary_10_1016_j_molimm_2008_09_027 crossref_primary_10_1111_imr_12314 crossref_primary_10_1093_eurheartj_ehr124 crossref_primary_10_1016_j_aanat_2023_152048 crossref_primary_10_1016_j_molimm_2009_06_005 crossref_primary_10_1080_07853890903110994 crossref_primary_10_1097_CRD_0b013e318279e907 |
Cites_doi | 10.1111/j.1749-6632.2001.tb03946.x 10.1161/01.ATV.19.8.1960 10.1161/01.CIR.104.2.197 10.4049/jimmunol.166.12.7514 10.1161/01.ATV.10.3.470 10.1016/S0026-0495(98)90203-7 10.4049/jimmunol.169.6.2892 10.1161/01.ATV.19.4.1105 10.1172/JCI118589 10.1172/JCI10124 10.1161/hq0901.094248 10.1074/jbc.M111727200 10.1073/pnas.100448997 10.1078/0171-2985-00159 10.1038/nature01323 10.4049/jimmunol.164.11.5866 10.1161/01.ATV.0000143933.20616.1b 10.1074/jbc.273.43.28438 10.1016/S0092-8674(03)00758-X 10.1016/S1262-3636(07)70084-8 10.1152/ajplung.2000.278.2.L365 10.1016/j.cyto.2005.02.006 10.1079/PNS2001110 10.1172/JCI116495 10.1002/eji.200323972 10.1016/S0022-1759(98)00160-4 10.1161/01.CIR.0000148135.08582.97 10.1161/01.ATV.0000104027.52895.D7 10.4049/jimmunol.174.3.1532 10.1073/pnas.95.20.11869 10.1161/01.ATV.18.4.615 10.1074/jbc.271.42.26174 10.1161/01.ATV.18.4.631 10.1038/nri1528 10.1016/S1521-6616(03)00042-1 10.1097/00002281-200401000-00005 10.1038/labinvest.3780331 10.1146/annurev.immunol.21.120601.140954 10.1016/0021-9150(85)90138-8 10.1183/09031936.03.00060603 10.1152/ajplung.2000.279.3.L468 10.1161/01.CIR.103.12.1681 10.1046/j.1365-2249.2002.01992.x 10.1152/ajplung.00487.2005 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION |
DOI | 10.1152/ajpheart.01105.2005 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1522-1539 |
EndPage | H2294 |
ExternalDocumentID | 10_1152_ajpheart_01105_2005 16387789 ajpheart_290_6_H2286 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - 02 23M 2WC 39C 4.4 53G 5GY 5VS 8M5 ABFLS ABPTK ACIWK ACPRK ADACO ADBBV AENEX AFFNX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BKOMP C1A DIK DL E3Z EBS EJD F5P GX1 H13 KQ8 O0- OK1 P2P PQEST PQQKQ RAP RHF RHI RPL UKR WH7 WOQ --- 3O- 6J9 AAFWJ ABJNI ACBEA BKKCC BTFSW CGR CUY CVF ECM EIF EMOBN ITBOX NPM RPRKH TR2 W8F XSW YSK YYP ~02 AAYXX CITATION |
ID | FETCH-LOGICAL-c461t-f2e394ebdc5768fb622ea5431542559eea2a35e4178ad57f278fb60c45b11a373 |
ISSN | 0363-6135 |
IngestDate | Thu Nov 21 21:13:37 EST 2024 Sat Sep 28 07:52:50 EDT 2024 Mon May 06 11:36:55 EDT 2019 Tue Jan 05 17:57:06 EST 2021 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c461t-f2e394ebdc5768fb622ea5431542559eea2a35e4178ad57f278fb60c45b11a373 |
PMID | 16387789 |
ParticipantIDs | highwire_physiology_ajpheart_290_6_H2286 crossref_primary_10_1152_ajpheart_01105_2005 pubmed_primary_16387789 |
PublicationCentury | 2000 |
PublicationDate | 20060601 2006-Jun 2006-06-00 |
PublicationDateYYYYMMDD | 2006-06-01 |
PublicationDate_xml | – month: 06 year: 2006 text: 20060601 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | American journal of physiology. Heart and circulatory physiology |
PublicationTitleAlternate | Am J Physiol Heart Circ Physiol |
PublicationYear | 2006 |
References | R38A R41 R40 R21 R20 R42 R23 R22 R25 R24 R27 R26 R29 R28 R1 R2 R3 R4 R5 R6 R7 R8 R9 R30 R10 R32 R31 R12 R34 R11 R33 R14 R36 R13 R35 R16 R38 R15 R37 R18 R17 R39 R9A R19 |
References_xml | – ident: R38 doi: 10.1111/j.1749-6632.2001.tb03946.x – ident: R7 doi: 10.1161/01.ATV.19.8.1960 – ident: R19 doi: 10.1161/01.CIR.104.2.197 – ident: R42 doi: 10.4049/jimmunol.166.12.7514 – ident: R32 doi: 10.1161/01.ATV.10.3.470 – ident: R15 doi: 10.1016/S0026-0495(98)90203-7 – ident: R4 doi: 10.4049/jimmunol.169.6.2892 – ident: R31 doi: 10.1161/01.ATV.19.4.1105 – ident: R37 doi: 10.1172/JCI118589 – ident: R24 doi: 10.1172/JCI10124 – ident: R36 doi: 10.1161/hq0901.094248 – ident: R35 doi: 10.1074/jbc.M111727200 – ident: R40 doi: 10.1073/pnas.100448997 – ident: R5 doi: 10.1078/0171-2985-00159 – ident: R23 doi: 10.1038/nature01323 – ident: R25 doi: 10.4049/jimmunol.164.11.5866 – ident: R3 doi: 10.1161/01.ATV.0000143933.20616.1b – ident: R17 doi: 10.1074/jbc.273.43.28438 – ident: R10 doi: 10.1016/S0092-8674(03)00758-X – ident: R11 doi: 10.1016/S1262-3636(07)70084-8 – ident: R9 doi: 10.1152/ajplung.2000.278.2.L365 – ident: R9A doi: 10.1016/j.cyto.2005.02.006 – ident: R6 doi: 10.1079/PNS2001110 – ident: R22 doi: 10.1172/JCI116495 – ident: R26 doi: 10.1002/eji.200323972 – ident: R39 doi: 10.1016/S0022-1759(98)00160-4 – ident: R33 doi: 10.1161/01.CIR.0000148135.08582.97 – ident: R14 doi: 10.1161/01.ATV.0000104027.52895.D7 – ident: R20 doi: 10.4049/jimmunol.174.3.1532 – ident: R2 doi: 10.1073/pnas.95.20.11869 – ident: R30 doi: 10.1161/01.ATV.18.4.615 – ident: R34 doi: 10.1074/jbc.271.42.26174 – ident: R8 doi: 10.1161/01.ATV.18.4.631 – ident: R41 doi: 10.1038/nri1528 – ident: R21 doi: 10.1016/S1521-6616(03)00042-1 – ident: R27 doi: 10.1097/00002281-200401000-00005 – ident: R28 doi: 10.1038/labinvest.3780331 – ident: R12 doi: 10.1146/annurev.immunol.21.120601.140954 – ident: R29 doi: 10.1016/0021-9150(85)90138-8 – ident: R18 doi: 10.1183/09031936.03.00060603 – ident: R13 doi: 10.1152/ajplung.2000.279.3.L468 – ident: R1 doi: 10.1161/01.CIR.103.12.1681 – ident: R16 doi: 10.1046/j.1365-2249.2002.01992.x – ident: R38A doi: 10.1152/ajplung.00487.2005 |
SSID | ssj0005763 |
Score | 2.1214294 |
Snippet | 1 Medical Biotechnological Center, University of Southern Denmark, and 2 Department of Pathology, Odense University Hospital, Odense, Denmark; 3 Department of... Surfactant protein D (SP-D) is an important innate immune defense molecule that mediates clearance of pathogens and modulates the inflammatory response.... |
SourceID | crossref pubmed highwire |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | H2286 |
SubjectTerms | Animals Animals, Newborn Aorta - pathology Atherosclerosis - chemically induced Atherosclerosis - metabolism Atherosclerosis - pathology Blotting, Western Cells, Cultured Cytokines - biosynthesis Dietary Fats - pharmacology Half-Life Humans Immunohistochemistry Inflammation - pathology Lipid Metabolism Mice Mice, Inbred C57BL Mice, Knockout Myocardium - pathology Pulmonary Surfactant-Associated Protein D - genetics Pulmonary Surfactant-Associated Protein D - isolation & purification Pulmonary Surfactant-Associated Protein D - toxicity Reverse Transcriptase Polymerase Chain Reaction RNA - biosynthesis RNA - isolation & purification Tumor Necrosis Factor-alpha - metabolism |
Title | Surfactant protein D is proatherogenic in mice |
URI | http://ajpheart.physiology.org/cgi/content/abstract/290/6/H2286 https://www.ncbi.nlm.nih.gov/pubmed/16387789 |
Volume | 290 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkBAvCDZg5Ut5QAhppCSOHTePEwPKpiIQnbQ3YyeO1ImmVUgf4K_nznY-NooEvESRP-LIv5N1d777HSHPRVlkNMrLUCW6DJnOppYDMoyx5HRktM4sldL8Yzo7Z6cX_GI0-jqIWto2epL_3JlX8j-oQhvgilmy_4Bs91FogHfAF56AMDz_CuMv2xoTE2BzjizfwrI6OsEK5ZgmhYrdGmYuc3RprHyIW0c4217UDJgjrJPDetknmJ1Uu9jzfFljqKq9i-9HdI6ZdW0q78R5X6NPt3Mmz1XhO05N1V8ZmctvvozKGZjpfRjwuq5cVOIH7yMYuCLakKkuBSsBW9Txj7THK3XlQL0cDQ_LGaWOBvv3Y5wjLay63GBV72aCOgq3_q_haMBis7LIok4phCtFdI09u-26QW4iVSJWVzj73PPJg7WVtLfZ-OOelwrWf71jdWSY9d-7qsa01NLXbBOroyzukjveuAiOnaTcIyNT7ZOD4wrQW_0IXgSfOvz2ya25j6o4IJNejgIvR8FJsPweXJWjAJpRju6T83dvF29moa-jEeYsjZuwpCbJmNFFjsZlqVNKjUIOBM7QoDRGUZVww2IxVQUXJRU4KMoZ13GsEpE8IHvVujKHJIgUyzTMZlrkzGRTHSkDSpDSIhVlruIxedVui9w4uhRpzUxOZbuh0m4o1j_lY8LarZO9CEv0viwAx24KyJBMpZUXuSnKMXm5a1q3wGD4mDx0iPS_4xF89Meex-R2L91PyF5Tb81TUD0b_cxKzy9IwIQf |
link.rule.ids | 314,780,784,27924,27925 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Surfactant+protein+D+is+proatherogenic+in+mice&rft.jtitle=American+journal+of+physiology.+Heart+and+circulatory+physiology&rft.au=Sorensen%2C+Grith+L&rft.au=Madsen%2C+Jens&rft.au=Kejling%2C+Karin&rft.au=Tornoe%2C+Ida&rft.date=2006-06-01&rft.issn=0363-6135&rft.volume=290&rft.issue=6&rft.spage=H2286&rft_id=info:doi/10.1152%2Fajpheart.01105.2005&rft_id=info%3Apmid%2F16387789&rft.externalDocID=16387789 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0363-6135&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0363-6135&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0363-6135&client=summon |